Sujal Shah's Net Worth
Sujal Shah's net worth is estimated to be at least $2,815,043.15 as of 12/24/2024. CoreStreet's estimation of Sujal Shah's net worth is based on their sale of stock and current holding of stock.
Sujal Shah is CEO at Cymabay Therapeu. They have executed at least 14 trades of stock as per SEC Form 4 filings. Their most recent trade was for 64,865 units of CBAY stock on 12/11/2023. Their biggest sale was on 12/11/2023 when they sold 64,865 units of Cymabay Therapeu stock for $1,297,300.00. They typically trade 2 times per year.
Total value of insider buys:
- $596,716.95
Total value of insider sells:
- $2,218,326.20
Most recent insider trade:
- Dec. 11, 2023
Sujal Shah's Insider Trading History
| Cymabay Therapeu | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 11, 2023 | CEO | 64,865 | $20.00 | Sell | $1,297,300.00 |
Oct. 9, 2023 | CEO | 64,861 | $14.20 | Sell | $921,026.20 |
June 6, 2022 | CEO | 51,301 | $1.95 | Buy | $100,036.95 |
Oct. 10, 2019 | CEO | 5,000 | $4.30 | Buy | $21,500.00 |
Sept. 23, 2019 | CEO | 5,000 | $5.53 | Buy | $27,650.00 |
Sept. 20, 2019 | CEO | 1,900 | $5.50 | Buy | $10,450.00 |
Dec. 21, 2018 | CEO | 10,000 | $6.54 | Buy | $65,400.00 |
Oct. 15, 2018 | CEO | 5,000 | $9.90 | Buy | $49,500.00 |
July 27, 2018 | CEO | 5,000 | $10.90 | Buy | $54,500.00 |
May 11, 2018 | CEO | 5,000 | $10.65 | Buy | $53,250.00 |
July 20, 2017 | Insider | 10,000 | $7.34 | Buy | $73,400.00 |
April 5, 2016 | CFO | 55,000 | $1.39 | Buy | $76,450.00 |
April 4, 2016 | CFO | 22,000 | $1.39 | Buy | $30,580.00 |
May 18, 2015 | CFO | 10,000 | $3.40 | Buy | $34,000.00 |